Population Dose-Hgb modelling of daprodustat across five Phase 3 studies in chronic kidney disease (CKD) patients with anemia.

Therapeutic area :

Noort van N., Berg van den P., Post T.M.,  Beerahee M., Mahar K.M., Yang S.

Population Dose-Hgb modelling of daprodustat across five Phase 3 studies in chronic kidney disease (CKD) patients with anemia. ACoP 2022. [Link to publication]